Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

被引:204
|
作者
Perrino, Cinzia
Prasad, Sathyamangla V. Naga
Mao, Lan
Noma, Takahisa
Yan, Zhen
Kim, Hyung-Suk
Smithies, Oliver
Rockman, Howard A.
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2006年 / 116卷 / 06期
关键词
D O I
10.1172/JCI25397
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (beta AR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by beta AR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
引用
收藏
页码:1547 / 1560
页数:14
相关论文
共 50 条
  • [21] Atorvastatin Attenuates Pressure Overload-induced Cardiac Hypertrophy and Dysfunction Through Enhanced Autophagy
    Zhao, Zhuo
    Wang, Wei
    Wang, Hua-Ting
    Geng, Qing-Xin
    Zhao, Di
    Su, Guohai
    CIRCULATION RESEARCH, 2015, 117
  • [22] Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy
    Li, Ming-Hui
    Zhang, Yao-Jun
    Yu, Yi-Hui
    Yang, Shao-Hua
    Iqbal, Javaid
    Mi, Qiong-Yu
    Li, Bing
    Wang, Zhi-Mei
    Mao, Wen-Xing
    Xie, Hong-Guang
    Chen, Shao-Liang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 728 : 67 - 76
  • [23] Hawthorn alters remodeling and ameliorates LV dysfunction in pressure overload-induced cardiac hypertrophy
    Hwang, Hyun Seok
    Ghannam, Michael M. J.
    Boluyt, Marvin O.
    Converso, Kimber
    Russell, Mark W.
    Bleske, Barry E.
    FASEB JOURNAL, 2007, 21 (06): : A1260 - A1260
  • [24] Loss of nrf2 exacerbates cardiac hypertrophy and dysfunction in response to pressure-overload
    Partridge, Charles R.
    Lewis, Robert K.
    Kingery, Justin R.
    Ramos, Kenneth S.
    Prabhu, Sumanth D.
    CIRCULATION, 2007, 116 (16) : 102 - 103
  • [25] Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction
    Zhang, Yan
    Zhang, Xiao-Fei
    Gao, Lu
    Liu, Yu
    Jiang, Ding-Sheng
    Chen, Ke
    Yang, Qinglin
    Fan, Guo-Chang
    Zhang, Xiao-Dong
    Huang, Congxin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (02): : 232 - 244
  • [26] Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction
    Phrommintikul, Arintaya
    Tran, Lavinia
    Kompa, Andrew
    Wang, Bing
    Adrahtas, Anastasia
    Cantwell, Danielle
    Kelly, Darren J.
    Krum, Henry
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (04): : H1804 - H1814
  • [27] Chronic sympathectomy improves survival and attenuates cardiac dysfunction in experimental pressure-overload hypertrophy
    Perlini, S
    Ferrero, I
    Fallarini, S
    Palladini, G
    Tozzi, R
    Radaelli, A
    Busca, G
    Fogari, R
    Ferrari, AU
    JOURNAL OF HYPERTENSION, 2003, 21 : S221 - S222
  • [28] The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
    Tojima, Mikuto
    Katanasaka, Yasufumi
    Shimizu, Satoshi
    Funamoto, Masafumi
    Shimizu, Kana
    Sunagawa, Yoichi
    Hasegawa, Koji
    Morimoto, Tatsuya
    CIRCULATION, 2021, 144
  • [29] Administration of oral nitrite and cardiac dysfunction following pressure overload induced hypertrophy - A preliminary study
    Kondo, Kazuhisa
    Bhushan, Shashi
    Lefer, David
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 24 : S39 - S39
  • [30] Cardiac fibroblasts in pressure overload hypertrophy: the enemy within?
    Bursac, Nenad
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (07): : 2850 - 2853